An interventional study of intramedullary nailing augmentation and intramedullary nailing in Hip Fracture of Intertrochanteric Type, sponsored by Diego Matías Domínguez Prado. Recruiting at 6 sites in Spain. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by Diego Matías Domínguez Prado · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Hip Fractures with a site in Spain — 10 open to participants now, 10 under way, none of them phase 3. Hip Fractures · Spain.
Among the 49 studies in Hip Fractures with a site in Spain, this one is the 10th largest by planned enrollment of the 38 interventional ones that give a count, is one of 6 that started in 2024, is one of 22 with no phase, and was the 43rd registered.
843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.
Browse Hip Fractures studies →10 of the 49 studies in Hip Fractures with a site in Spain are open now. Recruiting first, the newest first:
University of Southern California · Sites in Spain, United States, Canada and 2 more countries
Ages 60+
Cardenal Herrera University · Sites in Spain
Ages 65+
Hospital Álvaro Cunqueiro · Sites in Spain
Ages 18+
Elda University Hospital · Sites in Spain
Ages 50+
Population Health Research Institute · Sites in Spain, United States, Australia and 17 more countries
Ages 45+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: 75 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 314 is above the median of 86 across 534 interventional studies indexed under Hip Fractures.
Median enrollment 168 across the 38 interventional studies, 198 across the 11 observational. Of the 27 that completed or were terminated, 2 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 49 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Diego Matías Domínguez Prado as lead sponsor.
Diego Matías Domínguez Prado has 1 study filed under Hip Fractures — fewer than ten, so there is no comparison to draw.
3 of the studies in Hip Fractures with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06634290Diego Matías Domínguez PradoInfluence of Cemented Cephalic Augmentation on the Outcome of Intramedullary Nailing in Pertrochanteric Hip Fractures | 2026-12-31 |
| NCT04796350AgNovos Healthcare, LLCRESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | 2027-04-01 |
| NCT04743765Population Health Research InstituteHIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial | 2027-08-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 49 studies in Hip Fractures with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if small modifications in the surgical technique for the treatment of some kind of hip fractures, improve the result of the surgery. This small modification includes the addition of surgical bone cement to part of the intramedullary nail used in the surgery, to find out if it provides more stability to the construct and represents an improvement in the surgery result.
The main question it aims to answer is:
Does the addition of bone cement produces a decrease in complications related to mechanical failure of the implant used in the surgery and a decrease in the need for re-operation?
Researchers will compare adding this bone cement to the standard surgical technique without it.
Patients will:
Hypothesis
The hypothesis of the study assumes that cephalic augmentation with polymethylmethacrylate cement of the intramedullary nail in the surgical treatment of pertrochanteric hip fractures due to fragility, produces a decrease in complications in relation to mechanical failure of the implant and a decrease in the re-operation rate.
Objectives
The main objective seeks to compare the mechanical failure rates of the implant between intramedullary nailing with and without cephalic augmentation with polymethylmethacrylate cement.
The secondary objectives are to compare the perioperative, 1-month, and 1-year mortality rates of patients treated with intramedullary nailing with and without cephalic augmentation and to evaluate the safety of the surgical technique.
Design
For these purposes, a multicenter, controlled, randomized, single-blind, parallel groups, clinical trial will be carried out.
Participants
Patients over 75 years old, diagnosed with pertrochanteric hip fracture due and requiring surgical intervention, will be eligible for inclusion in the study. All patients will receive surgical treatment using the intramedullary nailing technique, which is the current gold standard treatment for this type of fractures.
Recruitment
Almost all patients who suffer a hip fracture require urgent attention for this process, as well as hospital admission. From the first moment of admission through the emergency room or during the time of hospitalization prior to surgery, the patient and/or their legal representative, will receive pertinent information about the diagnosis, prognosis and treatment of this pathology by and Orthopedic Surgeon.
At the same time that they receive this information, either the principal investigator, or one of the collaborating researchers, will additionally provide information about the study and will recruit patients to participate in it. Prior to the surgery, informed consent will be granted to participate in the research study and the corresponding documents will be signed, along with the usual surgical informed consent used in each institution for this specific pathology,
Given the characteristics of this pathology and the benefit it represents in terms of functional recovery and improved survival, if the surgical intervention is performed in the first 48 hours from the occurrence of the fracture, in some of the patients participating in the study, it may be the case that the operation is performed in less than 24 hours from the acceptance and signing of the informed consent.
Randomization
The patients included in the study will be randomly distributed into two groups, experimental and control. The experimental or CEMENT group will include patients treated with intramedullary nailing WITH cephalic augmentation, and the control or NO CEMENT group will include patients treated with intramedullary nailing WITHOUT cephalic augmentation. Once participation in the study has been accepted and the informed consents have been signed, the randomization process will proceed in the different groups as follows.
The use of a centralized computer system that generates the randomization sequence and performs the registration of the participants, concealment of the randomization sequence and group allocation, is currently the most recommended procedure for conducting clinical trials. For this study, the OxMaR computer system (acronym for Oxford Minimization and Randomization) was used. Each investigator will assign a code to each recruited patient that is recorded in the online randomization form, along with the type of fracture and the patient's sex, which are included as minimization variables.
Description of the intervention
Once the participants have been recruited for the study and have been randomly assigned to the experimental or control group, the surgical intervention will be carried out following the principles of usual clinical practice.
The patient will be operated by an orthopedic surgeon hospital following the usual protocol of the hospital and surgical technique. The implant used will be in all cases an intramedullary nail. Depending on whether the patient has been included in the experimental or control group, surgery will be performed by adding augmentation with polymethylmethacrylate cement to the cephalic component or not.
Regarding blinding, the patient will remain blind to the assignment to one group or another and only the surgeon and the researchers will know the group to which they have been assigned to, given that cement augmentation is easily identifiable for them in a standard radiological control taken during follow-up.
The rest of the follow-up will follow the usual clinical practice during hospital admission and subsequently on an outpatient basis, with controls in outpatient clinics at one month, three months, six months and one year post-intervention. A radiological control will be taken in all follow-ups. Both the clinical follow-up by the surgeon and the radiological follow-up are the same as those carried out in normal clinical practice for this type of pathology. No greater number of visits, consultations, complementary tests, procedures or additional participation are required from the patient for participating in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients diagnosed of pertrochanteric hip fracture treated with intramedullary nailing WITH cephalic augmentation using bone cement
Device: intramedullary nailing augmentation
Patients diagnosed of pertrochanteric hip fracture treated with intramedullary nailing WITHOUT cephalic augmentation
Device: intramedullary nailing
Treatment of pertrochanteric hip fractures with intramedullary nailing with cephalic augmentation with bone cement
Also known as: Osteosynthesis
Treatment of pertrochanteric hip fractures with intramedullary nailing without cephalic augmentation
Also known as: osteosynthesis
Mechanical failure rate of the implant
Defined as the intolerable loss of reduction of the fracture and the failure of osteosynthesis due to breakage or disassembly of the implant used, which requires surgical reintervention.
Time frame: From date of surgery until the date of mechanical failure diagnosis, assessed up to 52 weeks
Perioperative mortality rate
Proportion of participants who die compared to the total participants during hospital stay, assessed up to a maximum of 7 days
Time frame: From date of surgery until the date of hospital discharge, assessed up to a maximum of 7 days
One-month mortality rate
Proportion of participants who die compared to the total participants during a period of 30 days
Time frame: From date of surgery up to 30 days
One-year mortality rate
Proportion of participants who die compared to the total participants during a period of 52 weeks
Time frame: From date of surgery up to 52 weeks
Plan to share: Yes — All collected IPD. Anonymized.
Supporting information: Study protocol, Informed consent form
Time frame: Starting 3 months after publication of results
Access criteria: Researchers who wish to access data for meta-analysis. Data sharing must be approved by principal research who can be contacted by e-mail.
No publications or documents are linked to this record.
Started Sep 2024 (actual). Primary completion is estimated for Dec 2026, 27 months after the start.
Of 221 non-industry interventional studies with no phase under Hip Fractures, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 55. This study's planned 27 months is close to that.
Counting every sponsor, half of 237 studies reached it within 29 months; a quarter within 10 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.